☆ 4.3 Article

Emerging insights and future prospects for therapeutic application of siRNA targeting angiotensinogen in hypertension

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Small interfering RNA: Discovery, pharmacology and clinical development-An introductory review

Priyanga Ranasinghe et al.

Summary: Post-transcriptional gene silencing can be achieved through siRNA therapy, which uses synthetic short double-stranded RNA molecules to specifically target and degrade mRNA transcripts. This technology offers advantages such as broad targeting capabilities and long-lasting effects. However, challenges in terms of pharmacokinetics and pharmacodynamics have been addressed through chemical modification and delivery systems. Several siRNA therapies have been approved for clinical use, but further advancements are needed to target organs beyond the liver and reach special sites.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension

Akshay S. Desai et al.

Summary: Zilebesiran, an investigational RNA interference therapeutic agent, showed dose-dependent decreases in serum angiotensinogen levels and sustained blood pressure-lowering effect for up to 24 weeks in patients with hypertension. High-salt diet attenuated the blood pressure-lowering effect, while coadministration with irbesartan augmented the effect. Mild injection-site reactions were observed in a few patients throughout the study.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Peripheral Vascular Disease

Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association

Niteesh K. Choudhry et al.

Summary: The widespread treatment of hypertension and improvements in blood pressure have led to a decline in heart disease and stroke, but there is still a gap between public health targets and actual blood pressure control rates. Medication nonadherence is a key factor contributing to this gap, and the scientific statement aims to summarize its impact and strategies for improving adherence.

HYPERTENSION (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Delivery of RNA Therapeutics: The Great Endosomal Escape!

Steven F. Dowdy et al.

Summary: RNA therapeutics have great potential to treat various human diseases, but the challenge lies in overcoming the cellular barriers to achieve effective delivery.

NUCLEIC ACID THERAPEUTICS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Conventional Vasopressor and Vasopressor-Sparing Strategies to Counteract the Blood Pressure-Lowering Effect of Small Interfering RNA Targeting Angiotensinogen

Estrellita Uijl et al.

Summary: The study found that conventional vasopressors can raise arterial pressure after depletion of liver angiotensinogen by siRNA, providing potential pharmacological means to regulate the blood pressure-lowering effect of angiotensinogen siRNA for future therapeutic implementation.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor-Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen-Targeting Small Interfering RNA

Priyanga Ranasinghe et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

The growth of siRNA-based therapeutics: Updated clinical studies

M. May Zhang et al.

Summary: After more than twenty years since the discovery of the natural gene-silencing mechanism of RNA interference, siRNA-based therapeutics have entered the pharmaceutical market with three approved drugs and many others in advanced stages of development. The majority of late-stage candidates are targeted towards rare diseases or patients who have not responded to current treatments, while some have potential for a wider patient population. This review provides an overview of siRNA mechanisms, barriers to delivery, and profiles of approved drugs and candidates in Phase 3 clinical trials.

BIOCHEMICAL PHARMACOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Hypertension: Current trends and future perspectives

Paul G. Hunter et al.

Summary: Hypertension is a significant global health issue linked to cardiovascular disease and chronic conditions. Improving blood pressure control is crucial, with personalized treatment for different chronic diseases and research on new therapies being a priority to address this issue.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Inhibition of the renin-angiotensin system causes concentric hypertrophy of renal arterioles in mice and humans

Hirofumi Watanabe et al.

Summary: By studying mice and human subjects, it was found that deletion of renin or inhibition of the RAS may lead to concentric thickening of intrarenal arteries and arterioles, causing severe diseases such as blood flow obstruction, focal ischemia, and fibrosis. This is due to the expansion and transformation of renin cells, highlighting the importance of further morphological studies in humans to understand the extent of renal vascular damage from the use of RAS inhibitors.

JCI INSIGHT (2021)

添加到收藏夹

Article Medicine, General & Internal

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Bin Zhou et al.

Summary: Global prevalence of hypertension doubled from 1990 to 2019, with significant improvements in detection, treatment, and control rates. In 2019, 59% of women and 49% of men with hypertension were previously diagnosed, while treatment rates were 47% for women and 38% for men, with control rates at 23% for women and 18% for men. Disparities exist across countries, with some middle-income nations now outperforming high-income countries in hypertension management.

LANCET (2021)

添加到收藏夹

Review Urology & Nephrology

Targeting angiotensinogen with RNA-based therapeutics

Liwei Ren et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)

添加到收藏夹

Article Peripheral Vascular Disease

Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals

Alexander J. Lawson et al.

JOURNAL OF HYPERTENSION (2020)

添加到收藏夹

Article Medicine, General & Internal

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

Kausik K. Ray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia

Frederick J. Raal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Investigating the pharmacodynamic durability o f GalNAc-siRNA conjugates

Christopher R. Brown et al.

NUCLEIC ACIDS RESEARCH (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis

Nida Buawangpong et al.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Adherence in Hypertension A Review of Prevalence, Risk Factors, Impact, and Management

Michel Burnier et al.

CIRCULATION RESEARCH (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

The current state and future directions of RNAi-based therapeutics

Ryan L. Setten et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiorenal Syndrome Pathophysiology

Ujjala Kumar et al.

CARDIOLOGY CLINICS (2019)

添加到收藏夹

Article Peripheral Vascular Disease

Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen

Estrellita Uijl et al.

HYPERTENSION (2019)

添加到收藏夹

Article Peripheral Vascular Disease

National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015

Tiffany E. Chang et al.

HYPERTENSION (2019)

添加到收藏夹

Review Peripheral Vascular Disease

Nocturnal Hypertension New Technology and Evidence

Kazuomi Kario

HYPERTENSION (2018)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Reversal of siRNA - mediated gene silencing in vivo

Ivan Zlatev et al.

NATURE BIOTECHNOLOGY (2018)

添加到收藏夹

Review Physiology

ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY

Steven J. Forrester et al.

PHYSIOLOGICAL REVIEWS (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Structural Foundations of RNA Silencing by Argonaute

Jessica Sheu-Gruttadauria et al.

JOURNAL OF MOLECULAR BIOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Nonadherence to antihypertensive drugs A systematic review and meta-analysis

Tadesse Melaku Abegaz et al.

MEDICINE (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Synthesis of 5′-GalNAc-Conjugated Oligonucleotides: A Comparison of Solid and Solution-Phase Conjugation Strategies

Isaiah Cedillo et al.

MOLECULES (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Overcoming cellular barriers for RNA therapeutics

Steven F. Dowdy

NATURE BIOTECHNOLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Angiotensin II for the Treatment of Vasodilatory Shock

Ashish Khanna et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Medicine, General & Internal

A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

Kevin Fitzgerald et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines

Jinho Park et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

添加到收藏夹

Review Medicine, General & Internal

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

Dena Ettehad et al.

LANCET (2016)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

Anders Wittrup et al.

NATURE BIOTECHNOLOGY (2015)

添加到收藏夹

Article Biotechnology & Applied Microbiology

A holistic approach to targeting disease with polymeric nanoparticles

Christopher J. Cheng et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

添加到收藏夹

Article Peripheral Vascular Disease

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring

Gianfranco Parati et al.

JOURNAL OF HYPERTENSION (2014)

添加到收藏夹

Article Chemistry, Multidisciplinary

Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

Jayaprakash K. Nair et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice

Thazha P. Prakash et al.

NUCLEIC ACIDS RESEARCH (2014)

添加到收藏夹

Article Physiology

Classical Renin-Angiotensin System in Kidney Physiology

Matthew A. Sparks et al.

COMPREHENSIVE PHYSIOLOGY (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape

Jerome Gilleron et al.

NATURE BIOTECHNOLOGY (2013)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials

Harikrishna Makani et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

添加到收藏夹

Article Peripheral Vascular Disease

Nighttime Home Blood Pressure and the Risk of Hypertensive Target Organ Damage

Joji Ishikawa et al.

HYPERTENSION (2012)

添加到收藏夹

Article Medicine, General & Internal

Comparison of Dopamine and Norepinephrine in the Treatment of Shock.

Daniel De Backer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

Review Multidisciplinary Sciences

A three-dimensional view of the molecular machinery of RNA interference

Martin Jinek et al.

NATURE (2009)

添加到收藏夹

Article Peripheral Vascular Disease

Aliskiren, the first renin inhibitor for treating hypertension: Reactive renin secretion may limit its effectiveness

Jean E. Sealey et al.

AMERICAN JOURNAL OF HYPERTENSION (2007)

添加到收藏夹

Review Cell Biology

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

Puja K. Mehta et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.